Parkinson’s disease

Link between statin use and Parkinson’s disease risk: Study

Statins are a commonly prescribed drug used to lower cholesterol. Previous studies have also suggested that statins could offer protective properties against Parkinson’s disease, but the latest findings suggest the opposite. Researchers uncovered that there may be a slightly heightened risk for Parkinson’s disease among statin users—but it does not prove that statins cause Parkinson’s here to read more

Progress made in Parkinson’s disease research

Parkinson’s disease is a long-term degenerative disorder of the central nervous system. While some cases can be attributed to genetic inheritance or environmental factors, the majority of cases are considered idiopathic—having no specific cause. However, chemists from Konstanz sought out to develop a complex series of experiments that examined the effects of changing a single here to read more

Why strength training is important for those with Parkinson’s disease

Patients living with Parkinson’s disease may experience tremors, slower movement, and issues with balance that can inhibit their ability to exercise and keep their body strong. This has proven to be an issue, as without regular exercise that includes some measure of strength training, these symptoms can worsen as muscle mass decreases, making moving progressively here to read more

Dementia disorders like Parkinson’s and Alzheimer’s disease identified examining brushstrokes

Dementia disorders like Parkinson’s disease and Alzheimer’s disease may be identified with brushstrokes. In the study, researchers analyzed 2,092 paintings from seven famous artists who experienced both normal brain aging and neurodegenerative disease. Of the seven, two suffered from Parkinson’s disease, two had Alzheimer’s disease, and three were without neurodegenerative disease. The artists’ brushstrokes were here to read more

Parkinson’s disease risk may triple with depression: Study

Parkinson’s disease risk may triple with depression. Study author Albert C. Yang said, “Depression is linked in other studies to illnesses such as cancer and stroke. Our study suggests that depression may also be an independent risk factor for Parkinson’s disease.” The researchers analyzed medical records of 4,634 people with depression and 18,544 people without here to read more

Parkinson’s disease motor, non-motor signs and symptoms in elderly

Parkinson’s disease is a progressive ailment that affects the nervous system and thus movement. In many individuals, the first symptoms of Parkinson’s disease are mild, such as tremors in one hand, but the most common signs are stiffness and slowing of movement. Research shows that in people with Parkinson’s, nerve cells in the brain gradually here to read more

World Alzheimer’s Day: Cataracts, psoriasis, Parkinson’s disease, type 2 diabetes, and cholesterol

September 21 is World Alzheimer’s Day, so we present our top articles that discuss Alzheimer’s disease and related topics, including cataracts, psoriasis, Parkinson’s disease, type 2 diabetes, cholesterol, amyloid plaques, and traumatic brain injury. World Alzheimer’s Day aims to raise awareness about Alzheimer’s disease, which is growing as the world’s population continues to age. The here to read more

Traumatic brain injury associated with Parkinson’s disease, but not Alzheimer’s disease or incident dementia

Traumatic brain injury (TBI) with a loss of consciousness (LOC) has been found to be associated with later-life Parkinson’s disease, but not Alzheimer’s disease or incident dementia. The Centers for Disease Control and Prevention estimated that 1.3 million Americans visit the emergency room every year for a traumatic brain injury, so the later-effects of TBI here to read more

In Parkinson’s disease, dementia risk does not increase with anticholinergic drugs

In Parkinson’s disease (PD), dementia risk does not increase with anticholinergic drugs. Other studies have found a greater risk of Alzheimer’s disease (AD) and dementia associated with the anticholinergic drugs used to treat pain, bladder dysfunction, and mood. In Parkinson’s disease, anticholinergic drugs are used to improve motor and non-motor symptoms, and even though there here to read more

Early Parkinson’s disease-related weight loss and changes in eating habits indicate severity of the condition

Early Parkinson’s disease-related weight loss and changes in eating habits indicate the severity of future disease. The study, conducted by researchers at Massachusetts General Hospital (MGH), found that although weight loss is common in Parkinson’s disease, weight loss that occurs early on could be a sign of disease severity. Lead and corresponding author Dr. Anne-Marie Wills here to read more